M. Bonifazi (Ancona (AN), Italy), G. Margaritopoulos (London, United Kingdom), C. Ravaglia (Forlì, Italy), V. Alfieri (Parma (PR), Italy)
Systematic review: In vivo imaging in animal models relevant to drug-induced Interstitial lung disease (DIILD)
I. Mahmutovic Persson (Malmö, Sweden), K. Wachenfeldt (Lund, Sweden), K. Pindoria (Stevenage, United Kingdom), J. Delgado-San Martin (Stevenage, United Kingdom), S. Campbell (Stevenage, United Kingdom), M. Haase (Stevenage, United Kingdom), M. Wright (Stevenage, United Kingdom), J. Waterton (Manchester, United Kingdom), L. Olsson (Malmö, Sweden)
|  |
Antioxidant and anti-inflammation effect of GHK-Cu in bleomycin-induced pulmonary fibrosis
G. Hou (Shenyang, China), X. Zhou (Shenyang, China)
| |
Imaging biomarkers of oedema and fibrosis in a rat model of Drug-Induced-ILD
I. Mahmutovic Persson (Malmö, Sweden), A. öRbom (Lund, Sweden), P. öNnervik (Lund, Sweden), K. Wachenfeldt (Lund, Sweden), L. Olsson (Malmö, Sweden)
| |
Diagnostic value of serum KL-6 in Interstitial Lung Disease: preliminary results from an European cohort.
P. Millan Billi (Barcelona, Spain), I. Castellví (Barcelona, Spain), L. Martinez Martinez (Barcelona, Spain), F. Aparicio (Barcelona, Spain), T. Franquet (Barcelona, Spain), O. Sibila Vidal (Barcelona, Spain), D. Castillo Villegas (Barcelona, Spain)
| |
Investigating microbial communities in interstitial lung disease by standard culture of bronchioalveolar lavage samples
M. Bangham (London, United Kingdom), K. Myall (London, United Kingdom)
| |
Levels of YKL-40 in serum and sputum of patients diagnosed with hypersensitivity pneumonitis: A pilot study.
M. Cruz Carmona (Barcelona, Spain), M. De Homdedeu (Barcelona, Spain), S. Sanchez-Diez (Barcelona, Spain), I. Ojanguren (Barcelona, Spain), C. Romero-Mesones (Barcelona, Spain), A. Villar (Barcelona, Spain), F. Morell (Barcelona, Spain), X. MuñOz (Barcelona, Spain)
| |
Screening and characterization of activin A inhibitory peptides by phage display technology
V. Bastos (Uberlândia, Brazil), A. Souza (Uberlândia, Brazil), P. Fujimura (Uberlândia, Brazil), R. Silva (Uberlândia, Brazil), T. Cunha (Uberlândia, Brazil), L. Maia (Uberlândia, Brazil), L. Goulart (Uberlândia, Brazil)
|  |
Antinuclear antibodies in interstitial lung diseases: Prevalence and predictive factors
S. Aouadi (Ariana, Tunisia), N. Ghrairi (Ariana, Tunisia), I. Ben Ali (Ariana, Tunisia), I. Sahnoun (Ariana, Tunisia), S. Maalej (Ariana, Tunisia), S. Yalaoui (Ariana, Tunisia), L. Douik-Elgharbi (Ariana, Tunisia)
| |
Bronchoalveolar lavage in healthy and diseased individuals
B. Frye (Freiburg, Germany), J. Schupp (Freiburg, Germany), T. Köhler (Freiburg, Germany), G. Zissel (Freiburg, Germany), W. Vach (Freiburg, Germany), J. Müller-Quernheim (Freiburg, Germany)
| |
Validation of the ILD-GAP model in a Singapore population
M. Kam (Singapore, Singapore), H. Li (Singapore, Singapore), Y. Tan (Singapore, Singapore), S. Low (Singapore, Singapore)
| |
Role of gastroesophageal reflux in interstitial lung disease associated to connective tissue disease.
C. Diaz Cuña (Montevideo, Uruguay), S. Consani (Montevideo, Uruguay), V. Torres (Montevideo, Uruguay), F. Alonso (Montevideo, Uruguay), A. Bérez (Montevideo, Uruguay)
| |
Interstitial Pneumonia with Autoimmune Features (IPAF): a single center prospective experience
G. Sambataro (catania, Italy), S. Torrisi (catania, Italy), A. Vancheri (catania, Italy), M. Pavone (catania, Italy), R. Rosso (catania, Italy), M. Schisano (catania, Italy), C. Crimi (catania, Italy), D. Sambataro (catania, Italy), C. Vancheri (catania, Italy)
| |
Comparative survival analysis between idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis: Retrospective cohort study.
M. Alberti (Buenos Aires, Argentina), M. Fernandez (Buenos Aires, Argentina), L. Fassola (Buenos Aires, Argentina), F. Caro (Buenos Aires, Argentina), F. Paulin (Buenos Aires, Argentina)
| |
Club cells in histological patterns of interstitial lung diseases
P. Reynaud ( Montpellier, France), I. Serre ( Montpellier, France), I. Vachier ( Montpellier, France), A. Fort ( Montpellier, France), C. Vernisse ( Montpellier, France), M. Romagnoli (Bologne, Italy), G. Durand ( Montpellier, France), Y. Cabon ( Montpellier, France), S. Bommart ( Montpellier, France), A. Gamez ( Montpellier, France), A. Bourdin ( Montpellier, France)
| |
Progression of Rheumatoid-arthritis associated interstitial lung disease by radiological subtype
S. Sukhmani (London, United Kingdom), K. Myall (London, United Kingdom), B. Lams (London, United Kingdom), S. Agarwal (London, United Kingdom), A. West (London, United Kingdom)
| |
Non Specific Interstitial Pneumonia and features of connective tissue disease:what are the consequences of a different point of view?
A. Biffi (Monza, Italy), G. Dei (Monza, Italy), A. Stainer (Monza, Italy), F. De Giacomi (Monza, Italy), M. Pozzi (Monza, Italy), P. Faverio (Monza, Italy), A. Pesci (Monza, Italy)
| |
Impulse oscillometry compared to standard lung function testing in patients with idiopathic pulmonary fibrosis
E. Flensborg (Aarhus, Denmark)
| |
Change of primary Sjören’s syndrome-associated interstitial lung disease in computerized tomogram of chest during two years.
S. Uh (Seoul, Republic of Korea), B. Lee (Seoul, Republic of Korea), S. Koo (Seoul, Republic of Korea), Y. Kim (Seoul, Republic of Korea), K. Kim (Seoul, Republic of Korea), D. Kim (Bucheon, Republic of Korea)
| |